Cargando…

SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression

Scavenger receptor class A member 5 (SCARA5) has been reported to be implicated in several types of cancer. However, its biological roles and mechanism of SCARA5 in gastric cancer (GC) have not been elucidated. In the present study, SCARA5 expression was found to be downregulated in GC which was ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hangyu, Liu, Changgang, Wang, Xinbo, Wang, Yongfang, Zheng, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974898/ https://www.ncbi.nlm.nih.gov/pubmed/33758617 http://dx.doi.org/10.7150/jca.52426

Ejemplares similares

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

SCARA5 plays a critical role in the commitment of mesenchymal stem cells to adipogenesis
por: Lee, Hyemin, et al.
Publicado: (2017)

ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer
por: Wu, Jing, et al.
Publicado: (2017)

SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway
por: Wang, Jinwei, et al.
Publicado: (2021)

Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5
por: Chen, Chi-Yuan, et al.
Publicado: (2018)

SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
por: Zhang, Xiaotian, et al.
Publicado: (2022)

Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells
por: Liu, J, et al.
Publicado: (2013)

Identification of SCARA3 with potential roles in metabolic disorders
por: Peng, Hui, et al.
Publicado: (2020)

SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation
por: Liu, Hongliang, et al.
Publicado: (2018)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)

Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition
por: Yang, Zhuying, et al.
Publicado: (2019)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways
por: Huang, Juan, et al.
Publicado: (2023)

FZD5 prevents epithelial-mesenchymal transition in gastric cancer
por: Dong, Dan, et al.
Publicado: (2021)

Aldolase A as a prognostic factor and mediator of progression via inducing epithelial–mesenchymal transition in gastric cancer
por: Jiang, Zhonghua, et al.
Publicado: (2018)

SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer
por: Kim, Jeeho, et al.
Publicado: (2022)

MeCP2 inhibits proliferation and migration of breast cancer via suppression of epithelial‐mesenchymal transition
por: Jiang, Wei, et al.
Publicado: (2020)

Celastrus orbiculatus extract suppresses the epithelial-mesenchymal transition by mediating cytoskeleton rearrangement via inhibition of the Cofilin 1 signaling pathway in human gastric cancer
por: Wang, Haibo, et al.
Publicado: (2017)

BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression
por: Liu, Shu-Cheng, et al.
Publicado: (2022)

Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches
por: Kozak, Joanna, et al.
Publicado: (2020)

Lamp2 inhibits epithelial-mesenchymal transition by suppressing Snail expression in HCC
por: Zheng, Hao, et al.
Publicado: (2018)

Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma
por: Jumai, Kawuli, et al.
Publicado: (2022)

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
por: Kurata, Toru, et al.
Publicado: (2018)

Aqueous Huaier Extract Suppresses Gastric Cancer Metastasis and Epithelial to Mesenchymal Transition by Targeting Twist
por: Xu, Zhiyuan, et al.
Publicado: (2017)

The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC
por: Peng, Qi, et al.
Publicado: (2021)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

3BDO inhibits the proliferation, epithelial-mesenchymal transition (EMT), and stemness via suppressing survivin in human glioblastoma cells
por: Wang, Zhaotao, et al.
Publicado: (2022)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition
por: PENG, YANG, et al.
Publicado: (2014)

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017)

MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition
por: Peng, Man, et al.
Publicado: (2017)

Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition
por: Xu, Su, et al.
Publicado: (2017)

Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells
por: Lee, Da-Young, et al.
Publicado: (2021)

MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial–mesenchymal transition
por: Jiang, Shi-Bin, et al.
Publicado: (2016)

ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017)

microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rduk664o44v7qfjp7m8qii50a5